Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis
暂无分享,去创建一个
Mario Plebani | Giuseppe Lippi | Brandon Michael Henry | G. Lippi | M. Plebani | G. Aggarwal | B. Henry | J. Vikse | Jens Vikse | Stefanie Benoit | Gaurav Aggarwal | Johnny Wong | S. Benoit | J. Wong
[1] Mario Plebani,et al. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis , 2020, Clinical chemistry and laboratory medicine.
[2] G. Lippi,et al. D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis , 2020, Thrombosis and Haemostasis.
[3] Xiaofang Pei,et al. The Coronavirus Disease 2019 (COVID-19) Pandemic. , 2020, The Tohoku journal of experimental medicine.
[4] Analysis of clinical characteristics and laboratory findings of 95 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a retrospective analysis , 2020, Respiratory Research.
[5] Y. Xiong,et al. Clinical features and treatment of COVID‐19 patients in northeast Chongqing , 2020, Journal of medical virology.
[6] Rui-guang Zhang,et al. Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] Mario Plebani,et al. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis , 2020, Clinica Chimica Acta.
[8] J. Xiang,et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.
[9] Qiurong Ruan,et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China , 2020, Intensive Care Medicine.
[10] Dechang Chen,et al. Heart injury signs are associated with higher and earlier mortality in coronavirus disease 2019 (COVID-19) , 2020, medRxiv.
[11] K. Yuen,et al. Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.
[12] Jing Yuan,et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury , 2020, Science China Life Sciences.
[13] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[14] Kefei Chen,et al. Viral infection in community acquired pneumonia patients with fever: a prospective observational study. , 2018, Journal of thoracic disease.
[15] Tao Zhang,et al. A Non-Invasive Laboratory Panel as a Diagnostic and Prognostic Biomarker for Thrombotic Microangiopathy: Development and Application in a Chinese Cohort Study , 2014, PloS one.
[16] H. Guzner-Gur,et al. Diagnostic and prognostic value of very high serum lactate dehydrogenase in admitted medical patients. , 2014, The Israel Medical Association journal : IMAJ.
[17] Z. Memish,et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study , 2013, The Lancet Infectious Diseases.
[18] L. Cantley,et al. Cancer Cell Metabolism , 2012 .
[19] A. Tsirigos,et al. Ketones and lactate increase cancer cell “stemness,” driving recurrence, metastasis and poor clinical outcome in breast cancer , 2011, Cell cycle.
[20] D. Sabatini,et al. Cancer Cell Metabolism: Warburg and Beyond , 2008, Cell.
[21] R. Erbel,et al. Acute myocardial infarction in thrombotic microangiopathies--clinical characteristics, risk factors and outcome. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[22] I. Hozo,et al. Estimating the mean and variance from the median, range, and the size of a sample , 2005, BMC medical research methodology.
[23] R. Perng,et al. Clinical Features and Outcomes of Severe Acute Respiratory Syndrome and Predictive Factors for Acute Respiratory Distress Syndrome , 2005, Journal of the Chinese Medical Association.
[24] R. Perng,et al. Eight-Month Prospective Study of 14 Patients With Hospital-Acquired Severe Acute Respiratory Syndrome , 2004, Mayo Clinic Proceedings.
[25] H. Meier‐Kriesche,et al. Death After Graft Loss: An Important Late Study Endpoint in Kidney Transplantation , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[26] M. Kjeld. An automated colorimetric method for the estimation of lactate dehydrogenase activity in serum. , 1972, Scandinavian journal of clinical and laboratory investigation.